Strata Critical Medical, Inc. (SRTAW) Stock Overview
Explore Strata Critical Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Strata Critical Medical, Inc. (SRTAW)
Key Financials
Key Financials
Market Cap
42.5K
P/E Ratio
-24.70
EPS (TTM)
$0.61
ROE
0.14%
SRTAW Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Strata Critical Medical, Inc. (NASDAQ: SRTAW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Strata Critical Medical, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of SRTAW on the NASDAQ shows an RSI of 0.00, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Strata Critical Medical, Inc.'s NASDAQ-traded stock include a P/E ratio of -24.70 and a market capitalization of 42.5K. Combined with our AI analysis, these give both institutional and retail investors a clear view of SRTAW on the NASDAQ.